InnoBioscience is committed to Research, Discovering, and
Developing innovative therapies addressing unmet medical needs
  InnoBioscience: Home


Investor Relations

We are a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of ​development in Auto-immune Disease, Multiple Sclerosis, Rheumatoid Arthritis, Alzheimer Disease, and Duchene Muscular Dystrophy. InnoBioscience is uniquely positioned to develop a portfolio of its own products to treat patients with these unmet medical needs. Developing strategic alliances and partnerships is an integral part of our corporate strategy. InnoBioscience is committed to collaborating with strategic partners with a shared passion for realizing the significant potential of future research and development for disease areas with high unmet medical need.

If you would like more information about building a partnership with InnoBioscience please leave your contact information below.

Name: *
E-mail: *
Message: *